BamSEC and AlphaSense Join Forces
Learn More

Endo Health Solutions Inc.

Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 139 pages Endo Finance Co. and Each of the Guarantors Party Hereto 5.75% Senior Notes Due 2022 Indenture Dated as of December 19, 2013 Wells Fargo Bank, National Association, Trustee
12/34/56
EX-4.18
from S-4 8 pages Third Supplemental Indenture
12/34/56
EX-4.17
from S-4 6 pages Second Supplemental Indenture
12/34/56
EX-4.16
from S-4 6 pages First Supplemental Indenture
12/34/56
EX-4.13
from S-4 8 pages Third Supplemental Indenture
12/34/56
EX-4.12
from S-4 6 pages Second Supplemental Indenture
12/34/56
EX-4.11
from S-4 6 pages First Supplemental Indenture
12/34/56
EX-4.8
from S-4 8 pages Seventh Supplemental Indenture
12/34/56
EX-4.7
from S-4 6 pages Sixth Supplemental Indenture
12/34/56
EX-4.6
from S-4 6 pages Fifth Supplemental Indenture
12/34/56
EX-4.5
from S-4 6 pages Fourth Supplemental Indenture
12/34/56
EX-4.4
from S-4 5 pages Third Supplemental Indenture
12/34/56
EX-4.3
from S-4 5 pages Second Supplemental Indenture
12/34/56
EX-4.2
from S-4 5 pages Supplemental Indenture
12/34/56
EX-4.3
from 8-K 136 pages Endo Pharmaceuticals Holdings Inc. and Each of the Guarantors Party Hereto 7 1/4% Senior Notes Due 2022 Indenture Dated as of June 8, 2011 Wells Fargo Bank, National Association, Trustee
12/34/56
EX-4.1
from 8-K 136 pages Endo Pharmaceuticals Holdings Inc. and Each of the Guarantors Party Hereto 7% Senior Notes Due 2019 Indenture Dated as of June 8, 2011 Wells Fargo Bank, National Association, Trustee
12/34/56
EX-4.1
from 8-K 133 pages Endo Pharmaceuticals Holdings Inc. and Each of the Guarantors Party Hereto 7.00% Senior Notes Due 2020 Indenture Dated as of November 23, 2010 Wells Fargo Bank, National Association, Trustee
12/34/56
EX-4.HTM
from SC 13D/A ~5 pages Endo Pharmaceuticals and the D.E. Shaw Group Agree to Settlement
12/34/56
EX-4.1
from 8-K 102 pages Endo Pharmaceuticals Holdings Inc. 1.75% Convertible Senior Subordinated Notes Due April 15, 2015 Indenture Dated as of April 15, 2008 the Bank of New York, as Trustee
12/34/56
EX-4.HTML
from SC 13D 5 pages July 27, 2007 Mr. Peter Lankau Chief Executive Officer Endo Pharmaceuticals Holdings, Inc. 100 Endo Boulevard Chadds Ford, Pa 19317 Dear Mr. Lankau: As You Are Aware D. E. Shaw Composite Portfolios L.L.C. and Certain of Its Affiliates (Collectively “We” or the “D. E. Shaw Group”) Beneficially Own Approximately 5.6% of the Outstanding Shares of Endo Pharmaceuticals Holdings Inc. (“Endp” or the “Company”)
12/34/56